Favenza 800 Tablet contains Favipiravir 800mg, an antiviral medication primarily used to treat influenza and other viral infections by inhibiting viral RNA-dependent RNA polymerase, thereby preventing viral replication. It is commonly prescribed for managing mild to moderate cases of COVID-19, especially in the early stages of infection, to reduce viral load and hasten recovery. Favipiravir is effective against a broad spectrum of RNA viruses and works by selectively targeting viral enzymes without affecting human DNA. Favenza 800 should be taken exactly as prescribed by a healthcare professional, typically with food to minimize gastrointestinal discomfort. Common side effects may include mild diarrhea, nausea, elevated liver enzymes, and increased uric acid levels; patients should be monitored for any adverse reactions. It is contraindicated in pregnant or breastfeeding women due to potential teratogenic effects and should be used cautiously in patients with liver or kidney impairment. Adequate hydration and regular medical follow-up are recommended during the course of therapy. Favenza 800 is a prescription-only medication and should not be used for self-medication or without proper medical guidance. Always inform your doctor about any other medications or underlying health conditions before starting treatment with Favipiravir.